Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.34%
SPX
-0.38%
IXIC
-0.31%
FTSE
+0.23%
N225
-0.65%
AXJO
+1.13%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
16.69B
Dividend Yield
0.00%
P/E Ratio
19.16
EPS
0.23
Revenue
4.24B
Avg. Volume
1.80M

Recently from Cashu

publisher logo
Cashu

Incyte Stock Surges Amid Positive Myelofibrosis Therapy Outlook and Wells Fargo Upgrade

3 days ago
publisher logo
Cashu

Incyte Corporation: Navigating Mixed Analyst Views in Biopharmaceutical Sector Challenges

12 days ago
publisher logo
Cashu

Incyte Corporation (INCY): Navigating Mixed Analyst Sentiments in Biopharmaceutical Landscape

14 days ago

About

What does INCY do?
Yte is a Wilmington, Delaware-based biopharmaceutical company with 2,524 employees, focusing on hematology/oncology and inflammation/autoimmunity therapeutic areas. Its product portfolio includes JAKAFI, MONJUVI, and PEMAZYRE, among others.
Sector
💻 Health Care
IPO
CEO
Employees
2,617
Headquarters
Delaware, USA
Website
http://www.incyte.com
Stocks
Health Care
incy
yte
NASDAQ: INCY
+0.53 (+0.61%)
86.73
USD
At close at Aug 21, 19:07 UTC
Summary
News
Signals
Benchmarks
Financials